White label – Pompe disease - ClinicalTrials.eu

Study of crinecerfont oral solution in children under 2 years old with congenital adrenal hyperplasia to evaluate safety and how the drug works in the body

Recruiting

2 1 1
Investigated Diseases:
- Adrenogenital syndrome
Investigated Drugs:
- Crinecerfont
Study of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo

Recruiting

3 1
Investigated Diseases:
- Vitiligo
Investigated Drugs:
- Ruxolitinib
+6
Study of ONL1204 eye injections to slow vision loss in patients with age-related macular degeneration and geographic atrophy

Recruiting

2 1
Investigated Drugs:
- XELAFASLATIDE
+3
Study of intrathecal S230815 to evaluate safety and effectiveness in children with KCNT1-related Developmental and Epileptic Encephalopathy

Recruiting

2 1 1
Investigated Drugs:
- S230815-2
Study of tildrakizumab to treat patients with chronic spontaneous urticaria who did not respond to previous treatments

Recruiting

2 1 1 1
Investigated Diseases:
- Chronic spontaneous urticaria
Investigated Drugs:
- Tildrakizumab
Study of etentamig and iberdomide treatment for patients with relapsed or refractory multiple myeloma

Recruiting

1 1 1
Investigated Diseases:
- Plasma cell myeloma
Investigated Drugs:
- Iberdomide
Study of nadofaragene firadenovec alone or with gemcitabine, docetaxel or pembrolizumab in adults with non-muscle invasive bladder cancer who did not respond to BCG therapy

Recruiting

3 1 1 1
Investigated Diseases:
- Bladder transitional cell carcinoma
Investigated Drugs:
Study comparing standard and reduced intensity treatment in patients with acute myeloid leukemia or chronic lymphocytic leukemia who have no detectable disease after initial therapy

Recruiting

3 1 1 1
Investigated Drugs:
Study of Glofitamab and Pirtobrutinib Treatment in Patients with Mantle Cell Lymphoma Who Have Failed Previous Therapy and in Previously Untreated Patients

Recruiting

2 1 1 1
Investigated Diseases:
- Mantle cell lymphoma
Investigated Drugs:
Study of olverembatinib with chemotherapy versus standard therapy in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

Recruiting

3 1 1 1
Investigated Diseases:
- Philadelphia positive acute lymphocytic leukaemia
- Acute lymphocytic leukaemia
Investigated Drugs:
+3

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies